(Q53588126)

English

Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor.

scientific article published in November 2006

Statements

Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit